37 related articles for article (PubMed ID: 1900878)
1. Synthesis and characterization of a protective peptide-based vaccine against Schistosoma mansoni.
Tarrab-Hazdai R; Schechtman D; Arnon R
Infect Immun; 1998 Sep; 66(9):4526-30. PubMed ID: 9712813
[TBL] [Abstract][Full Text] [Related]
2. Fifteen Years of Sm-p80-Based Vaccine Trials in Nonhuman Primates: Antibodies From Vaccinated Baboons Confer Protection
Zhang W; Le L; Ahmad G; Molehin AJ; Siddiqui AJ; Torben W; Karmakar S; Rojo JU; Sennoune S; Lazarus S; Khatoon S; Freeborn J; Sudduth J; Rezk AF; Carey D; Wolf RF; Papin JF; Damian R; Gray SA; Marks F; Carter D; Siddiqui AA
Front Immunol; 2020; 11():1246. PubMed ID: 32636844
[TBL] [Abstract][Full Text] [Related]
3. Expression of a 28-kilodalton glutathione S-transferase antigen of Schistosoma mansoni on the surface of filamentous phages and evaluation of its vaccine potential.
Rao KV; He YX; Kalyanasundaram R
Clin Diagn Lab Immunol; 2003 Jul; 10(4):536-41. PubMed ID: 12853382
[TBL] [Abstract][Full Text] [Related]
4. Peptides Derived of Kunitz-Type Serine Protease Inhibitor as Potential Vaccine Against Experimental Schistosomiasis.
Hernández-Goenaga J; López-Abán J; Protasio AV; Vicente Santiago B; Del Olmo E; Vanegas M; Fernández-Soto P; Patarroyo MA; Muro A
Front Immunol; 2019; 10():2498. PubMed ID: 31736947
[TBL] [Abstract][Full Text] [Related]
5.
Sulbarán G; Verissimo da Costa GC; Losada S; Peralta JM; Cesari IM
Pathogens; 2021 Dec; 11(1):. PubMed ID: 35055970
[TBL] [Abstract][Full Text] [Related]
6. Functional specific binding of testosterone to Schistosoma haematobium 28-kilodalton glutathione S-transferase.
Remoué F; Mani JC; Pugnière M; Schacht AM; Capron A; Riveau G
Infect Immun; 2002 Feb; 70(2):601-5. PubMed ID: 11796588
[TBL] [Abstract][Full Text] [Related]
7. Immune responses in hookworm infections.
Loukas A; Prociv P
Clin Microbiol Rev; 2001 Oct; 14(4):689-703, table of contents. PubMed ID: 11585781
[TBL] [Abstract][Full Text] [Related]
8. Systemic and mucosal immune responses after intranasal administration of recombinant Mycobacterium bovis bacillus Calmette-Guérin expressing glutathione S-transferase from Schistosoma haematobium.
Kremer L; Dupré L; Riveau G; Capron A; Locht C
Infect Immun; 1998 Dec; 66(12):5669-76. PubMed ID: 9826340
[TBL] [Abstract][Full Text] [Related]
9. Relationship of impairment of schistosome 28-kilodalton glutathione S-transferase (GST) activity to expression of immunity to Schistosoma mattheei in calves vaccinated with recombinant Schistosoma bovis 28-kilodalton GST.
Grzych JM; De Bont J; Liu J; Neyrinck JL; Fontaine J; Vercruysse J; Capron A
Infect Immun; 1998 Mar; 66(3):1142-8. PubMed ID: 9488407
[TBL] [Abstract][Full Text] [Related]
10. Induction of mucosal immune responses against a heterologous antigen fused to filamentous hemagglutinin after intranasal immunization with recombinant Bordetella pertussis.
Renauld-Mongénie G; Mielcarek N; Cornette J; Schacht AM; Capron A; Riveau G; Locht C
Proc Natl Acad Sci U S A; 1996 Jul; 93(15):7944-9. PubMed ID: 8755582
[TBL] [Abstract][Full Text] [Related]
11. Influence of preimmunization with tetanus toxoid on immune responses to tetanus toxin fragment C-guest antigen fusions in a Salmonella vaccine carrier.
Chabalgoity JA; Villareal-Ramos B; Khan CM; Chatfield SN; de Hormaeche RD; Hormaeche CE
Infect Immun; 1995 Jul; 63(7):2564-9. PubMed ID: 7790070
[TBL] [Abstract][Full Text] [Related]
12. Presentation of T-cell epitopes assembled as multiple-antigen peptides to murine and human T lymphocytes.
Grillot D; Valmori D; Lambert PH; Corradin G; Del Giudice G
Infect Immun; 1993 Jul; 61(7):3064-7. PubMed ID: 7685741
[TBL] [Abstract][Full Text] [Related]
13. T cell priming versus T cell tolerance induced by synthetic peptides.
Aichele P; Brduscha-Riem K; Zinkernagel RM; Hengartner H; Pircher H
J Exp Med; 1995 Jul; 182(1):261-6. PubMed ID: 7540654
[TBL] [Abstract][Full Text] [Related]
14. Antigenicity and immunogenicity of a multiple peptidic construction of the Schistosoma mansoni Sm-28 GST antigen in rat, mouse, and monkey. 1. Partial protection of Fischer rat after active immunization.
Wolowczuk I; Auriault C; Bossus M; Boulanger D; Gras-Masse H; Mazingue C; Pierce RJ; Grezel D; Reid GD; Tartar A
J Immunol; 1991 Mar; 146(6):1987-95. PubMed ID: 1900878
[TBL] [Abstract][Full Text] [Related]
15. Protective immunity in mice vaccinated with the Schistosoma mansoni P-28-1 antigen.
Wolowczuk I; Auriault C; Gras-Masse H; Vendeville C; Balloul JM; Tartar A; Capron A
J Immunol; 1989 Feb; 142(4):1342-50. PubMed ID: 2492579
[TBL] [Abstract][Full Text] [Related]
16. Schistosoma mansoni ex vivo lung-stage larvae excretory-secretory antigens as vaccine candidates against schistosomiasis.
El Ridi R; Tallima H
Vaccine; 2009 Jan; 27(5):666-73. PubMed ID: 19056448
[TBL] [Abstract][Full Text] [Related]
17. Functional analysis of a T cell line specific for antiidiotypic antibodies to a Schistosoma mansoni protective epitope. II. Induction of protective immunity in experimental rat schistosomiasis.
Velge-Roussel F; Auriault C; Damonneville M; Capron A
J Immunol; 1991 Dec; 147(11):3967-72. PubMed ID: 1719096
[TBL] [Abstract][Full Text] [Related]
18. Epitopic characterization and vaccinal potential of peptides derived from a major antigen of Schistosoma mansoni (Sm28 GST).
Auriault C; Wolowczuk I; Gras-Masse H; Marguerite M; Boulanger D; Capron A; Tartar A
Pept Res; 1991; 4(1):6-11. PubMed ID: 1724945
[TBL] [Abstract][Full Text] [Related]
19. Schistosoma mansoni: protective antigens.
Tendler M
Mem Inst Oswaldo Cruz; 1987; 82 Suppl 4():125-8. PubMed ID: 3151086
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
